Última hora

INPatna High Court Orders FIR Against SHO for Allegedly Breaking Man's Legs Over Caste INTLFive Killed in Gaza Overnight Israeli Strikes on Residential Area INUK-born Somali man jailed for 16 years for online blackmail and sexual exploitation INNew Zealand Extends Lead Over England on Day 4 INAIFF informs general body ISL to start September 4, club-led model undecided CRYPTO-ENBitcoin Digital-Credit Trade Falters Amid Margin Pressure INTLLebanon Reports New Israeli Airstrikes Amid Ceasefire Violations INTLDavid Raya's Journey: From Southport to Spain's World Cup Squad GLOBALMoscow Normalcy Shattered by Ukrainian Drone Attack on Oil Refinery INTLAustralia Detects First H5N1 Bird Flu Case in Migratory Seabird INPatna High Court Orders FIR Against SHO for Allegedly Breaking Man's Legs Over Caste INTLFive Killed in Gaza Overnight Israeli Strikes on Residential Area INUK-born Somali man jailed for 16 years for online blackmail and sexual exploitation INNew Zealand Extends Lead Over England on Day 4 INAIFF informs general body ISL to start September 4, club-led model undecided CRYPTO-ENBitcoin Digital-Credit Trade Falters Amid Margin Pressure INTLLebanon Reports New Israeli Airstrikes Amid Ceasefire Violations INTLDavid Raya's Journey: From Southport to Spain's World Cup Squad GLOBALMoscow Normalcy Shattered by Ukrainian Drone Attack on Oil Refinery INTLAustralia Detects First H5N1 Bird Flu Case in Migratory Seabird

Iniciar sesión

ScienceDaily

Estable1 noticias1 fuentesÚltima actualización: 25.05.2026

Temas relacionadoscancer immunotherapy NK cells small molecule drugs McGill University acute myeloid leukemia kidney cancer glioblastoma triple-negative breast cancer

Últimas noticias

New Study: Small Molecule Drugs Can Temporarily Boost NK Cells for Cancer Attack

Salud·25.05.2026Resumen IA

New Study: Small Molecule Drugs Can Temporarily Boost NK Cells for Cancer Attack

Canadian researchers discovered small molecule drugs can temporarily enhance Natural Killer (NK) cells' ability to attack aggressive cancer cells without genetic modification, potentially offering a safer, more affordable cancer immunotherapy.